CAPR – capricor therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Capricor Therapeutics (NASDAQ:CAPR) shareholder returns have been stellar, earning 113% in 5 years [Yahoo! Finance]
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock.
Capricor Therapeutics Inc (NASDAQ: CAPR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Capricor Therapeutics Inc (NASDAQ: CAPR) had its price target raised by analysts at LADENBURG THALM/SH SH from $24.00 to $25.00. They now have a "buy" rating on the stock.
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.
Form 8-K CAPRICOR THERAPEUTICS, For: May 14
Form 8-K CAPRICOR THERAPEUTICS, For: May 14
Form 10-Q CAPRICOR THERAPEUTICS, For: Mar 31
Form 8-K CAPRICOR THERAPEUTICS, For: May 13
Form 8-K CAPRICOR THERAPEUTICS, For: Apr 29
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.